T his study by Melzer et al.
T his study by Melzer et al. 1 examined factors related to the receipt of tobacco cessation medications for a cohort of veterans admitted for COPD. Factors examined included patient-level characteristics as well as inpatient tobacco control measures. The authors demonstrated the stark gap in overall prescription of cessation medications: only 16.9 % of these high-risk patients received a tobacco cessation medication at discharge. They further demonstrated the continued disparities in who receives cessation medications. The authors showed that these patients tended to be younger, white, without significant psychiatric or medical comorbidities, and with fewer markers of COPD severity. Effectively, the most high-risk of this already risky cohort were not receiving the medications they needed. This paper is a call to providers, administrators, and researchers that progress is desperately needed. With such clear adverse outcomes, tobacco use must be targeted and treated effectively and efficiently. These results raise multiple questions as to where we are failing our patients. Reports published nearly 10 years ago demonstrated low rates of counseling and medication prescriptions, with similar disparities. 4, 5 Could Melzer et al. have demonstrated improvements over time given their use of data spanning 2005 through 2012? Or, does this reflect frustration on the part of providers and patients based on limited success rates, leading to a lack of counseling or a lack of patient uptake? Perhaps, as Melzer raised, a sense of futility or lack of time on the part of providers? Or, are we lacking standardized procedures to ensure that the positive effects of inpatient tobacco control measures, which were seen in this article, are translated to outpatient prescriptions? Regardless, this important paper continues to drive home the difficult question of how we can most successfully help our patients in need.
